Cargando…

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac

OBJECTIVE: To quantitatively characterize the dosimetric effects of long on-couch time in prostate cancer patients treated with adaptive ultra-hypofractionated radiotherapy (UHF-RT) on 1.5-Tesla magnetic resonance (MR)-linac. MATERIALS AND METHODS: Seventeen patients consecutively treated with UHF-R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Lin-Rui, Tian, Yuan, Wang, Ming-Shuai, Xia, Wen-Long, Qin, Shi-Rui, Song, Yong-Wen, Wang, Shu-Lian, Tang, Yu, Fang, Hui, Tang, Yuan, Qi, Shu-Nan, Yan, Ling-Ling, Liu, Yue-Ping, Jing, Hao, Chen, Bo, Xing, Nian-Zeng, Li, Ye-Xiong, Lu, Ning-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893501/ https://www.ncbi.nlm.nih.gov/pubmed/36741014 http://dx.doi.org/10.3389/fonc.2023.1039901

Ejemplares similares

Similar Outcomes of Standard Radiotherapy and Hypofractionated Radiotherapy Following Breast-Conserving Surgery
por: Hou, Hai-Ling, et al.
Publicado: (2015)

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments
por: Chuong, Michael D., et al.
Publicado: (2022)

Comparison of Intensity Modulated Radiotherapy Treatment Plans Between 1.5T MR-Linac and Conventional Linac
por: Ding, Shouliang, et al.
Publicado: (2021)

Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer
por: Yang, Jing, et al.
Publicado: (2021)

Dosimetric Accuracy of MR-Guided Online Adaptive Planning for Nasopharyngeal Carcinoma Radiotherapy on 1.5 T MR-Linac
por: Ding, Shouliang, et al.
Publicado: (2022)

TESLA Linac-IP Simulations
por: White, Glen, et al.
Publicado: (2004)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
por: Oehler, Christoph, et al.
Publicado: (2022)

Travelling wave positron injector linac for TESLA
por: Flöttmann, K, et al.
Publicado: (1999)

Status of the TESLA Test Facility Linac
por: Weise, H
Publicado: (1996)

Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy
por: Sun, Guang-Yi, et al.
Publicado: (2021)

Adaptive radiotherapy: The Elekta Unity MR-linac concept
por: Winkel, Dennis, et al.
Publicado: (2019)

Evaluation of plan quality in radiotherapy planning with an MR-linac
por: van de Schoot, Agustinus J.A.J., et al.
Publicado: (2019)

MR-Linac Radiotherapy – The Beam Angle Selection Problem
por: Bijman, Rik, et al.
Publicado: (2021)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer
por: Song, Yajun, et al.
Publicado: (2023)

Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer
por: Wang, Shu-wen, et al.
Publicado: (2016)

Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
por: Dang, Jennifer, et al.
Publicado: (2022)

A retrospective study of hypofractionated radiotherapy for keloids in 100 cases
por: Wen, Ping, et al.
Publicado: (2021)

Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution
por: Blamek, Sławomir, et al.
Publicado: (2012)

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
por: Cuccia, Francesco, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

An evaluation of the use of EBT-XD film for SRS/SBRT commissioning of a 1.5 Tesla MR-Linac system
por: Lim, Seng Boh, et al.
Publicado: (2022)

Single and multi-bunch wakefield effects in the TESLA linac
por: Mosnier, A, et al.
Publicado: (1994)

Beam position monitors in the TESLA test facility Linac
por: Lorenz, R
Publicado: (1996)

Measurement of the Beam Position in the TESLA Test Facility Linac
por: Lorenz, R, et al.
Publicado: (1996)

Phase Space Tomography at the TESLA Test Facility Linac
por: Geitz, M A, et al.
Publicado: (1999)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020)

Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow
por: Mannerberg, Annika, et al.
Publicado: (2020)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
por: Mitchell, A., et al.
Publicado: (2022)

Clinical application of MR-Linac in tumor radiotherapy: a systematic review
por: Liu, Xin, et al.
Publicado: (2023)

Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging
por: Menten, Martin J., et al.
Publicado: (2020)

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UK
por: Teoh, Suliana, et al.
Publicado: (2023)

Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
por: Dunlop, Alex, et al.
Publicado: (2020)

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy
por: Alaghband, Yasaman, et al.
Publicado: (2023)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis
por: Cao, Ling, et al.
Publicado: (2016)

Faster and more accurate patient positioning with surface guided radiotherapy for ultra-hypofractionated prostate cancer patients
por: Mannerberg, Annika, et al.
Publicado: (2021)

The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
por: Miszczyk, Marcin, et al.
Publicado: (2022)

Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy
por: Wang, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eig96bqk8nrmfkdn05qbtq52qq